Major Changes to Medical Device Registration Process in Japan

November 10, 2014 by Stewart Eisenhart

Revised medical device registration and approval requirements in Japan will become law November 25, 2014, and will impact several compliance areas for foreign manufactures active in the market, According to Emergo’s Tokyo office.

Replacing the Pharmaceutical Affairs Law (PAL), the Pharmaceutical and Medical Device Law (PMDL) will affect all major components of Japanese device registration, including in-country representation, quality management system compliance, third-party certifications and regulation of medical software.

New package insert rules

The PMDL contains more comprehensive requirements for device package insert information than previous Japanese regulations. Manufacturers of Class I, II, III and IV devices must use up-to-date medical literature as well as safety and vigilance data to prepare their package insert materials. Proposed package insert materials must also be included in registrants’ premarket applications.

Changes to Marketing Authorization Holder system

In order to qualify as a Marketing Authorization Holder (MAH) to provide authorized representation to foreign manufacturers in Japan, firms must now not only employ three qualified managers but also implement their own quality systems based on the Ministry of Health, Labour and Welfare’s Ordinance No. 169.

In most cases, the PMDL also subjects MAHs to quality system conformity assessments on a product rather than a facility basis. A Certificate of QMS Conformance is issued to the MAH, and now covers:

– See more at:



Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *